poisar

Stocks · News reference

Analysts Update Ratings and Price Targets for ArriVent BioPharma

Fiscal.ai

Several financial analysts maintained buy ratings and updated price targets for ArriVent BioPharma (AVBP) on November 11, 2026.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading